Related Experiment Video
Updated: Aug 21, 2025
08:26
Clinical Application of Single-Surgeon, Three-Port, Laparoscopic Resection for Colorectal Cancer with Natural Orifice Specimen Extraction
Published on: March 24, 2023
606
Surgery for Crohn's disease: upfront or last resort?
1Division of Colorectal Surgery, New York-Presbyterian/Columbia University Medical Center, New York, USA.
Gastroenterology Report
|November 16, 2022
Summary
Early surgery for Crohn's disease (CD) may offer benefits in disease control and quality of life, potentially outweighing risks associated with delayed surgical intervention. This review examines evidence on optimal timing for CD surgery.
Area of Science:
- Gastroenterology
- Surgical Gastroenterology
- Inflammatory Bowel Disease Research
Background:
- Crohn's disease (CD) affects the entire gastrointestinal tract, causing diverse symptoms.
- Advancements in medical treatments for CD have led to surgery being considered a last resort.
- Delaying surgery in CD may result in poorer patient outcomes, including malnutrition and complications.
Purpose of the Study:
- To review the evidence on the optimal timing of surgical intervention in Crohn's disease.
- To evaluate the potential benefits of early surgery for disease control, symptom relief, and quality of life in CD patients.
Main Methods:
- Literature review of studies comparing early versus delayed surgical treatment for Crohn's disease.
- Analysis of evidence regarding patient outcomes, disease control, and quality of life.
Main Results:
- Delayed surgical intervention in CD can lead to increased patient morbidity and complications.
- Early surgical consideration may improve disease management and patient well-being.
Conclusions:
- The optimal timing for surgery in Crohn's disease requires careful consideration of individual patient factors and potential benefits.
- Evidence suggests that early surgical intervention might be advantageous in specific CD patient populations for better outcomes.
Related Concept Videos
01:21Inflammatory Bowel Disease V: Surgical Management
190
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
190
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
188
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
188
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
248
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
248
01:29Inflammatory Bowel Disease IV: Pharmacological Management
169
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
169
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
212
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
212
01:26Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
149
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
149